RabAvert (GSK Vaccines GmbH)
Welcome to the PulseAid listing for the RabAvert drug offered from GSK Vaccines GmbH. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | GSK Vaccines GmbH |
NON-PROPRIETARY NAME: | Rabies Vaccine |
SUBSTANCE NAME: | |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2014-07-08 |
END MARKETING DATE: | 2020-03-31 |
RabAvert VACCINE Details:
Item Description | RabAvert from GSK Vaccines GmbH |
LABELER NAME: | GSK Vaccines GmbH |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2014-07-08 |
END MARKETING DATE: | 2020-03-31 |
PRODUCT ID: | 63851-501_1e6d0596-d032-4f29-a94b-ca5ce32abe23 |
PRODUCT NDC: | 63851-501 |
APPLICATION NUMBER: | BLA103334 |